Pancreatic Cancer Research

ResearcherSpringer Nature (Germany)No recent work listed

Iain Dickson

Matched on OpenAlex author ID A5029547847.

Their work

Papers
16 (first author 16, last author 0)
Trials
0
Grants
0
Collaborators
0
Papers, trials and grants by year

2016: 6 papers · 2017: 2 papers · 2018: 3 papers · 2019: 3 papers · 2020: 1 paper · 2021: 1 paper

Papers 16

  1. Improved CAR T therapy for PDAC. First author DOI 10.1038/s41575-021-00476-8↗
  2. Tuft cells restrain PDAC progression. First author DOI 10.1038/s41575-020-00358-5↗
  3. Autophagy inhibitor combination strategies for pancreatic cancer. First author DOI 10.1038/s41575-019-0136-8↗
  4. CD11b agonism overcomes PDAC immunotherapy resistance. First author DOI 10.1038/s41575-019-0191-1↗
  5. AACR pancreatic cancer meeting. First author DOI 10.1038/s41575-019-0219-6↗
  6. Pancreatic cancer: Tailored therapy for pancreatic tumour subtype. First author DOI 10.1038/nrgastro.2017.163↗
  7. Pancreatic cancer: No risk from aspirin in pancreatic cancer. First author DOI 10.1038/nrgastro.2017.189↗
  8. Microbiome promotes pancreatic cancer. First author DOI 10.1038/s41575-018-0013-x↗
  9. Pancreatic cancer: Between ROCK and a hard place. First author DOI 10.1038/nrgastro.2017.59↗
  10. Pancreatic cancer: PDAC metastases show identical known driver gene mutations. First author DOI 10.1038/nrgastro.2017.9↗
  11. Pancreatic cancer: A new model for imaging tumour progression. First author DOI 10.1038/nrgastro.2016.105↗
  12. Pancreatic cancer: A role for redox regulation in PDAC. First author DOI 10.1038/nrgastro.2016.133↗
  13. Pancreatic cancer: Stromal-cancer cell crosstalk supports tumour metabolism. First author DOI 10.1038/nrgastro.2016.137↗
  14. Pancreatic cancer: γδ T cells support PDAC. First author DOI 10.1038/nrgastro.2016.156↗
  15. Pancreatic cancer: Mapping malignant tissue dynamics. First author DOI 10.1038/nrgastro.2016.164↗
  16. Pancreatic cancer: PanNETs elude elimination. First author DOI 10.1038/nrgastro.2016.67↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.